Oxford Nanopore Technologies has announced the appointment of Dr John Milton as director of Nanopore Chemistry and Clive Brown as director of Bioinformatics and IT.
The company develops nanopore technology within a molecular detection and analysis platform with a broad range of applications including DNA sequencing.
Dr Milton was previously senior director of research at Cambridge University spin-out Solexa, where he was principal architect of the sequencing-by-synthesis chemistry that formed the basis of the Genome Analyzer, now a leading second generation DNA sequencing technology.
Clive Brown joins Oxford Nanopore from the Wellcome Trust Sanger Institute (WTSI), where he played a key role in the adoption, operation and development of ‘next generation’ DNA sequencing platforms. Prior to this he was director of computational biology & IT at Solexa.
Oxford Nanopore chief executive Dr Gordon Sanghera said: ‘The appointment of two senior executives with an exceptional track record in sequencing technology reflects the acceleration of our programme to deliver a nanopore-based, label-free, single molecule sequencing system.’
He added: ‘Milton and Brown bring not only great technical expertise but also a deep understanding of sequencing applications. This knowledge will help us to develop a sequencing system that truly meets the needs of researchers.’